Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) said members of its management team will participate in multiple investor conferences in November–December 2025, including Guggenheim Healthcare (Boston) on Nov 10, 2025, Stifel Healthcare (New York) on Nov 12, 2025, Jefferies Global Healthcare (London) on Nov 18, 2025, Craig‑Hallum Alpha Select (New York) on Nov 18, 2025, and Evercore Healthcare (Miami) on Dec 2, 2025.

Several events offer live webcasts with listed times and management will hold one‑on‑one meetings throughout each conference. Live webcasts and archived recordings will be available via the company’s News & Events investor portal and recordings will remain available for 90 days after each meeting.

FLORHAM PARK, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following upcoming investor conferences:

Guggenheim Securities 2nd Annual Healthcare Innovation Conference in Boston, MA
Date: Monday, November 10, 2025
Live Webcast: 3:00 pm EST
Management to participate in one-on-one meetings throughout the conference

Stifel 2025 Healthcare Conference in New York, NY
Date: Wednesday, November 12, 2025
Live Webcast: 4:40 pm EST
Management to participate in one-on-one meetings throughout the conference

Jefferies Global Healthcare Conference in London, UK
Date: Tuesday, November 18, 2025
Live Webcast: 9:30 am EST / 2:30 pm GMT
Management to participate in one-on-one meetings throughout the conference

16th Annual Craig-Hallum Alpha Select Conference in New York, NY
Date: Tuesday, November 18, 2025
Management to participate in one-on-one meetings throughout the conference

8th Annual Evercore Healthcare Conference in Miami, FL
Date: Tuesday, December 2, 2025
Live Webcast: 3:25 pm EST
Management to participate in one-on-one meetings throughout the conference

To access the live webcast and archived recordings of each event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 90 days following the conclusion of each meeting.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB), for the U.S., Europe and Canada. Phathom currently markets vonoprazan in the United States as VOQUEZNA^® (vonoprazan) tablets for the relief of heartburn associated with Non-Erosive GERD in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, and as part of the VOQUEZNA^® TRIPLE PAK^® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA^® DUAL PAK^® (vonoprazan tablets, amoxicillin capsules) for the treatment of H. pylori infection in adults. For more information about Phathom, visit the company’s website at www.phathompharma.com and follow on LinkedIn and X.

MEDIA CONTACT
Nick Benedetto
1-877-742-8466
media@phathompharma.com

INVESTOR CONTACT
Eric Sciorilli
1-877-742-8466
ir@phathompharma.com

© 2025 Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals, Inc.

FAQ

When will Phathom Pharmaceuticals (PHAT) present at the Guggenheim Healthcare Innovation Conference?

Phathom management is scheduled to present on Monday, Nov 10, 2025 with a live webcast at 3:00 pm EST.

How can investors watch the Phathom (PHAT) conference webcasts and where are recordings posted?

Live webcasts and archived recordings are available on the company’s News & Events investor portal at investors.phathompharma.com/news-events/events-and-presentations.

For how long will Phathom (PHAT) conference recordings remain available after each meeting?

Recordings will be available for 90 days following the conclusion of each meeting.

What time is Phathom (PHAT) scheduled to webcast at the Jefferies Global Healthcare Conference in London?

The Jefferies webcast is scheduled for 9:30 am EST / 2:30 pm GMT on Nov 18, 2025.

Will Phathom (PHAT) management hold one‑on‑one investor meetings during these conferences?

Yes. Management will participate in one‑on‑one meetings throughout each listed conference.

Which Phathom (PHAT) events in November 2025 include a live webcast?

Guggenheim (Nov 10), Stifel (Nov 12), and Jefferies (Nov 18) list live webcasts with times in the announcement.